Lee Kyeong-Tae, Mun Goo-Hyun
Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-Dong 50, Gangnam-Gu, Seoul, 135-710, South Korea.
Microsurgery. 2017 Jan;37(1):75-83. doi: 10.1002/micr.22420. Epub 2015 Apr 23.
Superdrainage using superficial inferior epigastric vein (SIEV) has been often used to overcome occasional venous insufficiency in deep inferior epigastric perforator (DIEP) flap. However, a consensus regarding its clinical benefits is lacking. The aim of this review was to evaluate the efficacy of superdrainage using SIEV on clinical outcome in DIEP flap breast reconstruction by meta-analytic methodology.
Medline, Ovid and Google Scholar were searched to obtain all relevant publications. Pooled risks for perfusion-related complications were compared between the superdrainage group and control group by Mantel-Haenszel test.
Six studies representing 1,376 cases (842 superdrainage and 534 control group) were enrolled, all of which were retrospective cohort studies. Superdrainage had little influence on the risk of total flap loss (RR: 0.97, 95% CI: 0.36-2.57). There were trends toward decreasing risks of partial flap loss (RR: 0.59, 95% CI; 0.18-1.94) and fat necrosis (RR: 0.87, 95% CI: 0.58-1.30) in the superdrainage group, though they were not significant. The risk of partial flap necrosis in which partial flap loss and fat necrosis were combined, was reduced 20% in the superdrainage group, although statistical significance was not achieved (RR: 0.80, 95% CI: 0.57-1.11). The risk of flap congestion decreased significantly in the superdrainage group (RR: 0.06, 95% CI: 0.01-0.51).
Although there is obvious benefit of SIEV superdrainage in reducing the risk of flap congestion, evidence supporting its use to prevent flap compromise is still insufficient. Further studies would be required. © 2014 Wiley Periodicals, Inc. Microsurgery 37:75-83, 2017.
使用腹壁浅静脉(SIEV)进行超级引流常用于克服腹壁下深动脉穿支(DIEP)皮瓣偶尔出现的静脉功能不全。然而,对于其临床益处尚无共识。本综述的目的是通过荟萃分析方法评估使用SIEV进行超级引流对DIEP皮瓣乳房重建临床结局的疗效。
检索Medline、Ovid和谷歌学术以获取所有相关出版物。通过Mantel-Haenszel检验比较超级引流组和对照组灌注相关并发症的合并风险。
纳入了6项研究,共1376例患者(超级引流组842例,对照组534例),所有研究均为回顾性队列研究。超级引流对皮瓣完全坏死风险影响不大(RR:0.97,95%CI:0.36-2.57)。超级引流组部分皮瓣坏死(RR:0.59,95%CI:0.18-1.94)和脂肪坏死(RR:0.87,95%CI:0.58-1.30)风险有降低趋势,但未达显著水平。超级引流组部分皮瓣坏死(合并部分皮瓣丢失和脂肪坏死)风险降低20%,但未达统计学显著性(RR:0.80,95%CI:0.57-1.11)。超级引流组皮瓣充血风险显著降低(RR:0.06,95%CI:0.01-0.51)。
尽管SIEV超级引流在降低皮瓣充血风险方面有明显益处,但支持其用于预防皮瓣受损的证据仍不足。需要进一步研究。©2014威利期刊公司。《显微外科学》37:75-83,2017。